A woman in Switzerland with metastatic lung cancer who developed thin skin and was later diagnosed with Cushing’s syndrome was…
Andrea Lobo
Andrea Lobo is a Science writer at BioNews. She holds a Biology degree and a PhD in Cell Biology/Neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. She was a postdoctoral and senior researcher at the Institute for Research and Innovation in Health in Porto, in drug addiction, studying neuronal plasticity induced by amphetamines. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She authored multiple research papers in peer-reviewed journals. She shifted towards a career in science writing and communication in 2022.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Andrea Lobo
A young woman with Cushing’s disease and acromegaly — marked by the abnormal growth of certain body parts…
People with Cushing’s disease who have more education are also more likely to have better patient outcomes — including…
A 71-year-old man with Cushing’s disease developed avascular necrosis in the hips and shoulders, a condition in which bone…
A young woman who developed Cushing’s syndrome three years after being diagnosed with a metastatic neuroendocrine tumor saw her cortisol…
People with Cushing’s disease may have higher levels of cortisol and more severe symptoms than those with other forms…
Partial adrenalectomy, or the removal of only a portion of the adrenal gland containing a tumor instead of the entire…
Older Cushing’s disease patients less frequently present classical symptoms of the disease, and have more coexistent conditions and…
Long-term treatment with relacorilant led to a sustained decrease in blood pressure, blood sugar levels, and body weight in…
Korlym (mifepristone) significantly reduced levels of hemoglobin A1c, a marker that reflects blood sugar levels over the previous months,…